SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 319 filers reported holding SALIX PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.43 and the average weighting 1.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $34,482,000 | -26.4% | 300,000 | 0.0% | 18.91% | -22.2% |
Q3 2014 | $46,872,000 | +26.7% | 300,000 | 0.0% | 24.29% | +41.7% |
Q2 2014 | $37,005,000 | +19.1% | 300,000 | 0.0% | 17.14% | +13.7% |
Q1 2014 | $31,083,000 | +15.2% | 300,000 | 0.0% | 15.07% | -20.1% |
Q4 2013 | $26,982,000 | +34.5% | 300,000 | 0.0% | 18.87% | +89.9% |
Q3 2013 | $20,064,000 | +1.1% | 300,000 | 0.0% | 9.94% | +27.1% |
Q2 2013 | $19,845,000 | – | 300,000 | – | 7.82% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 467,943 | $30,954,000 | 11.01% |
TANG CAPITAL MANAGEMENT LLC | 300,000 | $19,845,000 | 7.82% |
OAK RIDGE INVESTMENTS LLC | 1,382,895 | $91,478,000 | 2.87% |
SECTOR GAMMA AS | 147,001 | $9,724,000 | 2.84% |
Credo Capital Management, LLC | 38,869 | $2,571,000 | 1.98% |
Cardinal Capital Management | 48,226 | $3,190,000 | 1.89% |
ZEVENBERGEN CAPITAL INVESTMENTS LLC | 626,800 | $41,463,000 | 1.68% |
HERNDON CAPITAL MANAGEMENT LLC | 1,284,472 | $84,967,823,000 | 1.27% |
CATAPULT CAPITAL MANAGEMENT LLC | 45,000 | $2,977,000 | 1.24% |
Pier Capital, LLC | 108,556 | $7,181,000 | 1.10% |